Subrahmanyam TALARI, A. Emmanuel KOLA, Bhuvaneswari CHALAPAKA, S. N. Murthy BODDAPATI

Synthesis of 2-aryl-5-(arylsulfonyl)-1,3,4-oxadiazoles as potent antibacterial and antioxidant agents

Ten novel 2-aryl-5-(arylsulfonyl)-1,3,4-oxadiazoles were produced and assessed for their in vitro antibacterial and antioxidant activities. Diverse spectroscopic methods like $^{1 H} NMR, ^{13}C$ NMR, IR, and LCMS were used for the characterization of the prepared samples and all the data was in good agreement with the anticipated structures. The prepared compounds 6a-j were screened for their in vitro antibacterial activity against bacterial strains Pseudomonas aeruginosa, Enterobacter aerogenes, Escherichia coli (grampositive), and Bacillus cerus, Staphylococcus aureus, Bacillus subtilis (gram-negative). The antimicrobial screening outcome revealed that the prepared 2-(3,4-dimethylphenyl)-5-tosyl-1,3,4-oxadiazole (6j), 2-(3-isopropylphenyl)-5-tosyl-1,3,4-oxadiazole (6c), and 2-(2-ethylphenyl)-5-tosyl-1,3,4-oxadiazole (6i) are most potent among all the examined compounds. Furthermore, the antioxidant activity of the prepared compounds was also investigated by DPPH radical scavenging method and the results showed that some of the compounds were moderately active.

PDF

___

1. N Malleshappa, MP Harun. 2,6-Di-substituted imidazo[2,1 b][1,3,4]thiadiazoles: Search for anticancer agents. European Journal of Medicinal Chemistry 2012; 56: 56-69. doi: 10.1016/j.ejmech.2012.08.012
2. V Asati, DK Mahapatra, SK Bharti. Thiazolidine-2,4-diones as multi-targeted scaffold in medicinal chemistry: Potential anticancer agents. European Journal of Medicinal Chemistry 2014; 87: 814-833. doi: 10.1016/j.ejmech.2014.10.025
3. ND James, JW Growcott. Zibotentan Endothelin ETA receptor antagonist oncolytic. Drugs of the Future 2009; 34: 624−633. doi: 10.1358/ dof.2009.34.8.1400202
4. Verma G, Khan MF, Akhtar W, Alam MM, Akhter M et al. A review exploring therapeutic worth of 1,3,4-oxadiazole tailored compounds. Mini-Reviews in Medicinal Chemistry 2019; 19: 477-509. doi: 10.2174/1389557518666181015152433
5. RM Jones, JN Leonard, DJ Buzard, Lehmann J. GPR119 agonists for the treatment of type 2 diabetes. Expert Opinion on Therapeutic Patents 2009; 19: 1339−1359. doi: 10.1517/13543770903153878
6. Boström J, Hogner A, Llinàs A, Wellner E, Plowright AT. Oxadiazoles in Medicinal Chemistry. Journal of Medicinal Chemistry 2012; 55: 1817–1830. doi: 10.1021/jm2013248
7. Ahmed MN, Sadiq B, Al-Masoudi NA, Yasin KA, Hameed S et al. Synthesis, crystal structures, computational studies and antimicrobial activity of new designed bis((5-aryl-1,3,4-oxadiazol-2-yl)thio)alkanes. Journal of Molecular Structure 2018; 1155: 403–413. doi: 10.1016/j. molstruc.2017.11.011
8. Desai NC, Bhatt N, Somani H, Trivedi A. Synthesis, antimicrobial and cytotoxic activities of some novel thiazole clubbed 1,3,4-oxadiazoles. European Journal of Medicinal Chemistry 2013; 67: 54-59. doi: 10.1016/j.ejmech.2013.06.029
9. Rabie AM. Two antioxidant 2,5-disubstituted-1,3,4-oxadiazoles (CoViTris2020 and ChloViD2020): Successful repurposing against COVID-19 as the first potent multitarget anti-SARS-CoV-2 Drugs. New Journal of Chemistry 2021; 45: 761-771. doi: 10.1039/ D0NJ03708G
10. Swain CJ, Baker R, Kneen C, Moseley J, Saunders J et al. Novel 5-HT3 antagonists. Indole oxadiazoles. Journal of Medicinal Chemistry 1991; 34: 140-151. doi: 10.1021/jm00105a021
11. Ladduwahetty T, Baker R, Cascieri MA, Chambers MS, Haworth K et al. N-heteroaryl-2-phenyl-3-(benzyloxy)piperidines: a novel class of potent orally active human NK1 antagonists. Journal of Medicinal Chemistry 1996; 39: 2907-2914. doi: 10.1021/jm9506534
12. Tully WR, Gardner CR, Gillespie RJ, Westwood R. 2-(Oxadiazolyl)- and 2-(thiazolyl)imidazo[1,2-a]pyrimidines as agonists and inverse agonists at benzodiazepine receptors. Journal of Medicinal Chemistry 1991; 34: 2060-2067. doi: 10.1021/jm00111a021
13. Saunders J, Cassidy M, Freedman SB, Harley EA, Iversen LL et al. Novel quinuclidine-based ligands for the muscarinic cholinergic receptor. Journal of Medicinal Chemistry. 1990; 33: 1128-1138. doi: 10.1021/jm00166a008
14. Chen C, Senanayake CH, Bill TJ, Larsen RD, Veshoeven TR et al. Improved fischer indole reaction for the preparation of N,Ndimethyltryptamines: synthesis of L-695,894, a potent 5-HT1D receptor agonist. The Journal of Organic Chemistry 1994; 59: 3738-3741. doi: 10.1021/jo00092a046
15. Diana GD, Volkots DL, Nitz TJ, Baily TR, Long MA E et al. Oxadiazoles as ester bioisosteric replacements in compounds related to disoxaril Antirhinovirus Activity. Journal of Medicinal Chemistry 1994; 37: 2421-2436. doi: 10.1021/jm00041a022
16. Vanjare BD, Choi NG, Prasad GM, Raza H, Hassan M et al. Novel 1,3,4-oxadiazole compounds inhibit the Tyrosinase and melanin level: synthesis, In-Vitro, and In-Silico studies. Bioorganic & Medicinal Chemistry 2021; 41: 116222. doi: 10.1016/j.bmc.2021.116222
17. Banerjee AG, Das N, Shengule SA, Srivastava RS, Shrivastava SK. Synthesis, characterization, evaluation and molecular dynamics studies of 5, 6–diphenyl–1,2,4–triazin–3(2H)–one derivatives bearing 5–substituted 1,3,4–oxadiazole as potential anti–inflammatory and analgesic agents. European Journal of Medicinal Chemistry 2015; 101: 81–95. doi: 10.1016/j.ejmech.2015.06.020
18. Wang P, Zhou L, Zhou J, Wu Z, Xue W et al. Synthesis and antibacterial activity of pyridinium-tailored 2,5-substituted-1,3,4-oxadiazole thioether/sulfoxide/sulfone derivatives. Bioorganic & Medicinal Chemistry Letters 2016; 26:1214–1217. doi: 10.1016/j.bmcl.2016.01.029
19. Bajaj S, Asati V, Singh J, Roy PP. 1,3,4-Oxadiazoles: An emerging scaffold to target growth factors, enzymes and kinases as anticancer agents. European Journal of Medicinal Chemistry 2015; 97: 124–141. doi: 10.1016/j.ejmech.2015.04.051
20. Wu W, Chen Q, Tai A, Jiang G, Ouyang G. Synthesis and antiviral activity of 2-substituted methylthio-5-(4-amino-2-methylpyrimidin-5- yl)-1,3,4-oxadiazole derivatives. Bioorganic & Medicinal Chemistry Letters 2015; 25: 2243–2246. doi: 10.1016/j.bmcl.2015.02.069
21. Khan MSY, Khan RM, Drabu S. Synthesis and anticonvulsant and antimicrobial activity of some new 1,3,4-oxadiazole derivatives. Indian Journal of Heterocyclic Chemistry 2001; 11: 119–122.
22. Kennedy DA, Summers LA. Chemical constitution and activity of bipyridinium herbicides. Part XIV. Reduction potential and herbicidal activity of 4,4′-(1,3,4-thiadiazole-2,5-diyl)- and 4,4′-(1,3,4-oxadiazole-2,5-diyl)bis(1-methylpyridinium) diiodides.Journal of Heterocyclic Chemistry 1981; 18: 409–410. doi: 10.1002/jhet.5570180236
23. Adelstein GW, Yen CH, Dajani EJ, Bainchi RG. 3,3-Diphenyl-3-(2-alkyl-1,3,4-oxadiazol-5-yl)propylcycloalkylamines, a novel series of antidiarrheal agents. Journal of Medicinal Chemistry 1976; 19: 1221–1225. doi: 10.1021/jm00232a010
24. Mazouz F, Lebreton L, Milcent R, Burstein C. 5-Aryl-1,3,4-oxadiazol-2(3H)-one derivatives and sulfur analogues as new selective and competitive monoamine oxidase type B inhibitors. European Journal of Medicinal Chemistry 1990; 25: 659–671. doi: 10.1016/0223- 5234(90)90131-L
25. Grinsztejn B, Nguyen BY, Katlama C, Gatell JM, Lazzarin A et al. Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial. The Lancet 2007; 369: 1261–1269. doi: 10.1016/S0140-6736(07)60597-2
26. Kashaw SK, Gupta V, Kashaw V, Mishra P, Stables J et al. Anticonvulsant and sedative-hypnotic activity of some novel 3-[5-(4-substituted) phenyl-1,3,4-oxadiazole-2yl]-2-styrylquinazoline-4(3H)-ones. Medicinal Chemistry Research 2010; 19: 250–261. doi: 10.1007/s00044- 009-9188-6
27. O’Neal JB, Rosen H, Russell PB, Adams AC, Blumenthal A. Potential hypoglycemic agents: 1,3,4-oxadiazoles and related compounds. Journal of Medicinal Chemistry 1962; 5: 617–626. doi: 10.1007/s00044-009-9188-6
28. Khan BA, Zafar S, Mughal EU, Ahmed MN, Hamdani SS et al. Design and synthesis of novel 1,3,4 oxadiazole derivatives bearing azo moiety as biologically significant scaffolds. Letters in Drug Design & Discovery 2018; 15: 1346-1355. doi: 10.2174/157018081566618032 6152204.
29. Ahmed MN, Sadiq B, Al-Masoudi NA, Yasin KA, Hameed S et al. Synthesis, crystal structures, computational studies and antimicrobial activity of new designed bis((5-aryl-1,3,4-oxadiazol-2-yl)thio)alkanes. Journal of Molecular Structure 2018; 1155: 403–413. doi: 10.1016/j. molstruc.2017.11.011
30. Kumar D, Pilania M, Arun V, Mishra B. A facile and expeditiousone-pot synthesis of α-Keto-1,3,4-oxadiazoles. Synlett 2014; 25: 1137– 1141. doi: 10.1055/s-0033-1340981
31. Zhang G, Yu Y, Zhao Y, Xie X, Ding C. Iron(III)/TEMPOcatalyzed synthesis of 2,5-disubstituted 1,3,4-oxadiazoles by oxidative cyclization under mild conditions. Synlett 2017; 28: 1373–1377. doi: 10.1055/s-0036-1588747
32. Guin S, Ghosh T, Rout SK, Banerjee A, Patel BK. Cu(II) catalyzed imine C–H functionalization leading to synthesis of 2,5-substituted 1,3,4-oxadiazoles. Organic Letters 2011; 13: 5976–5979. doi: 10.1021/ol202409r
33. Yu W, Huang G, Zhang Y, Liu H, Dong L et al. I2 - Mediated oxidative C–O bond formation for the synthesis of 1,3,4-oxadiazoles from aldehydes and hydrazides. The Journal of Organic Chemistry 2013; 78: 10337–10343. doi: 10.1021/jo401751h
34. Teimouri A, Salavati H, Chermahini AN. Synthesis, characterization and application of various types of alumina and nano-g-alumina sulfuric acid for the synthesis of 2,5-disubstituted-1,3,4-oxadiazoles. Acta Chimica Slovenica 2014; 61: 51–58
35. Wet-osot S, Phakhodee W, Pattawarapan M. Application of N-acylbenzotriazoles in the synthesis of 5-substituted 2-ethoxy1,3,4-oxadiazoles as building blocks towards 3,5-disubstituted 1,3,4-oxadiazol-2(3H)-ones. The Journal of Organic Chemistry 2017; 82: 9923–9929. doi: 10.1021/acs.joc.7b01863
36. Niu P, Kang J, Tian X, Song L, Liu H, Wu J et al. Synthesis of 2 amino-1,3,4-oxadiazoles and 2-amino-1,3,4-thiadiazoles via sequential condensation and I2- mediated oxidative C–O/C–S bond formation. The Journal of Organic Chemistry 2015; 80: 1018–1024. doi: 10.1021/ jo502518c
37. Dolman SJ, Gosselin F, O’Shea PD, Davies IW. Superior reactivity of thiosemicarbazides in the synthesis of 2-amino-1,3,4- oxadiazoles. The Journal of Organic Chemistry 2006; 71: 9548–9551. doi: 10.1021/jo0618730
38. Fang T, Tan Q, Ding Z, Liu B, Xu B. Pd-catalyzed oxidative annulation of hydrazides with isocyanides: synthesis of 2-amino-1,3,4- oxadiazoles. Organic Letters 2014; 16: 2342–2345. doi: 10.1021/ol5006449
39. Murthy BSN, Emmanuel KA, Babu KS, Babu BH. Temperature dependent regioselective synthesis of aryl tetrazole amines using copper source. Journal of Organometallic Chemistry 2018; 866: 177-183. doi: 10.1016/j.jorganchem.2018.04.027
40. Murthy BSN, Ramana T, Kumar GR, Sharmila N, Assal ME et al. Copper-Promoted One-Pot Approach: Synthesis of Benzimidazoles. Molecules 2020; 25: 1788. doi: 10.3390/molecules25081788
41. Kumar GR, Murthy BSN, Kumari MS, Babu BH. Synthesis of new (±)-1-(4-(3-fluorobenzyloxy)pyrrolidin-3-yl)-4-phenyl-1H-1,2,3-triazole derivatives via Click reaction and study of anti-cancer activity against HCT 116, MDA-MB231, Mia-PaCa2 Cell lines. Egyptian Journal of Chemistry 2020; 63: 2813-2825. doi: 10.21608/ejchem.2019.16652.2014
42. Rao SJM, Murthy BSN, Raghuram M, Adil SF, Rafi SM et al. $Pd(PPh_3)_4$ Catalyzed Synthesis Of Indazole Derivatives as Potent Anti Cancer Drug. Applied Sciences 2020; 10: 3792. doi: 10.3390/app10113792
43. Ramana MB, Vijay K, Reddy OS, Murthy BSN, Babu BH. Synthesis, cytotoxicity and antimicrobial evaluation of some new 2-Aryl, 5-substituted 1,3,4-oxadiazoles and1,3,4-thiadiazoles. Chemistry Africa 2019; 2: 15-20. doi: 10.1007/s42250-018-00034-x
44. Rao SJM , Murthy BSN, Raghuram M, Koduru GB, Babu BH. Novel Substituted Indazoles towards potential Antimicrobial Agents. Oriental Journal of Chemistry 2021; 37: 508-512. doi: 10.13005/ojc/370234
45. Furniss BS, Hannaford AJ, Smith PWG, Tatchell AR. In Vogel’s Textbook of Practical Organic Chemistry, Fifth Edition, Pearson Education Pte. Ltd., Indian Branch, Delhi, 2004; 928-929.
46. Alam MM, Almalki AS, Neamatallah T, Ali NM, Malebari AM et al. Synthesis of new 1, 3, 4-oxadiazole-ıncorporated 1, 2, 3-triazole moieties as potential anticancer agents targeting thymidylate synthase and their docking studies. Pharmaceuticals 2020; 13 (11): 390. doi: 10.3390/ph13110390
47. Shankaraiah M, Venkanna B, Jaya Shree A. Synthesis of 1, 3, 4-oxadiazole of NSAIDs and their biological properties. Asian Journal of Research in Chemistry 2018; 11 (1): 139-142. doi: 10.5958/0974-4150.2018.00029.9
48. Phatak PS, Sathe BP, Dhumal ST, Rehman NNMA, Dixit PP et al. Synthesis, antimicrobial evaluation and docking studies of substituted acetylphenoxymethyl-triazolyl-N-phenylacetamides. Journal of Heterocyclic Chemistry 2019; 56 (7): 1928–1938. doi: 10.1002/jhet.3568
49. Chew AL, Jessica JJA, Sasidharan S. Antioxidant and antibacterial activity of different parts of Leucas aspera. Asian Pacific Journal of Tropical Biomedicine 2012; 2 (3): 176–180. doi: 10.1016/S2221-1691(12)60037-9